AEON Biopharma, Inc. Shareholders' Equity
AEON Biopharma, Inc. (AEON) had Shareholders' Equity of -$15.36 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent -$15.36M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$16.75M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$55.03M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$19.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$15.36M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$16.75M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | -$55.03M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$19.87M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$15.85M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | -$11.32M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | -$28.57M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | -$32.09M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$27.95M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$198.38M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | -$153.04M 10-Q · filed 2025-11-14 | |
| 2023-09-30 | -$128.40M 10-Q/A · filed 2024-03-29 | -$121.74M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$11.46M 10-Q · filed 2023-07-21 | |
| 2023-03-31 | -$7.32M 10-Q · filed 2023-07-21 | |
| 2022-12-31 | -$287.50M 10-K/A · filed 2024-05-14 | -$9.44M 10-K · filed 2023-02-22 |
| 2022-09-30 | -$11.55M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$12.37M 10-Q · filed 2023-07-21 | |
| 2022-03-31 | -$14.16M 10-Q · filed 2023-07-21 | |
| 2021-12-31 | -$16.93M 10-Q · filed 2023-07-21 | |
| 2021-09-30 | -$17.18M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$22.84M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$18.84M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-06-15 |
| 2021-02-11 | $5.00M 10-Q · filed 2021-06-15 | |
| 2020-12-31 | $21.41K 10-K/A · filed 2023-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |